ITGAM and head and neck squamous cell carcinoma: Prior reports demonstrate that cisplatin-based chemoradiotherapy results in a profound decrease in circulating T-cell populations and a relative increase in CD33b+CD11b+HLADRlo monocytes (representative of MDSC-like populations) and Treg populations during HNSCC treatment [17].